we can only use a conceptual
framework based on prior literature using EAAs
containing LNAAs to manipulate neurotransmitters
(Pardridge, 1998). Our supplementation protocol used
EAAs (including LNAAs) to inhibit serotonin synthesis
as indicated by a lower free tryptophan:LNAA ratio
(Figure 4A; Pardridge, 1998).